Novotech

• A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study of Single and Multiple Ascending Doses of GV-100 (Part3)

  Collaborator, Phase 1, Not yet recruiting, 12 people, 10 Sept 2026

• A Phase 1, Open Label, non-randomised Drug-Drug interaction (DDI) for GV-100 (Part 4)

  Collaborator, Phase 1, Not yet recruiting, 12 people, 31 Aug 2026

• A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)

  Collaborator, Phase 3, Recruiting, 300 people, 22 Oct 2025

• NCT06279871

  Collaborator, Phase 3, Completed, 1,514 people, 28 Feb 2024

• NCT06125691

  Collaborator, Phase 1, Completed, 139 people, 9 Nov 2023

• NCT06013150

  Collaborator, Phase 1, Completed, 24 people, 28 Aug 2023

• Study of SPG302 in Healthy Volunteers and ALS Participants

  Collaborator, Phase 1, Completed, 88 people, 31 May 2023

• Phase I Clinical Trial of a Candidate HPV Vaccine

  Collaborator, Phase 1, Status unknown, 40 people, 5 Jan 2023

• An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients

  Collaborator, Phase 2, Terminated, 14 people, 15 Aug 2022

• NCT05152901

  Collaborator, Phase 1, Completed, 23 people, 10 Dec 2021

• NCT04814875

  Collaborator, Phase 1/2, Terminated, 16 people, 24 Mar 2021

Sources: anzctr.org.au, clinicaltrials.gov